Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD) (NCT03478826)

🧪 Interventions in This Study

• ILD (OTHER)
• Healthy (OTHER)
• Pneumonia (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Mayo Clinic — Rochester, Minnesota

📞 Contact the Study Coordinator

Phone: (507) 284-4862

Email: Stachowitz.Michael@mayo.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Interstitial Lung Disease

• Genentech Validation Tool for Pulmonary Fibrosis — New York, New York
• FAPI PET for Lung Fibrosis — Los Angeles, California
• Interstitial Lung Disease Research Unit Biobank — Kansas City, Kansas
• Hyperpolarized 129Xe MRI for Imaging Pulmonary Function — Durham, North Carolina
• Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough — Rochester, Minnesota
• Pulmonary Hypertension SOLAR — Durham, North Carolina

Explore by condition: All Interstitial Lung Disease clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.